ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Pavan Atluri
Timothy J. Gardner
Y. Joseph Woo
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atluri, P.
Right arrow Articles by Woo, Y. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atluri, P.
Right arrow Articles by Woo, Y. J.
Related Collections
Right arrow Myocardial infarction

Ann Thorac Surg 2006;81:1728-1736
© 2006 The Society of Thoracic Surgeons

Original article: Cardiovascular

Neovasculogenic Therapy to Augment Perfusion and Preserve Viability in Ischemic Cardiomyopathy

Pavan Atluri, MD a , George P. Liao, MB a , Corinna M. Panlilio, BA a , Vivian M. Hsu, BA a , Matthew J. Leskowitz a , Kevin J. Morine, BA b , Jeffrey E. Cohen, BA a , Mark F. Berry, MD a , Erik E. Suarez, MD a , Danielle A. Murphy, BS c , William M.F. Lee, MD, PhD c , Timothy J. Gardner, MD a , H. Lee Sweeney, PhD b , Y. Joseph Woo, MD *

a Division of Cardiothoracic Surgery, Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
b Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
c Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Accepted for publication December 1, 2005.

* Address correspondence to Dr Woo, Division of Cardiothoracic Surgery, Department of Surgery, University of Pennsylvania, Silverstein 6, 3400 Spruce St, Philadelphia, PA 19104; (Email: wooy{at}uphs.upenn.edu).

BACKGROUND: Ischemic cardiomyopathy is a global health concern with limited therapy. We recently described endogenous revascularization utilizing granulocyte-macrophage colony stimulating factor (GMCSF) to induce endothelial progenitor cell (EPC) production and intramyocardial stromal cell-derived factor-1{alpha} (SDF) as a specific EPC chemokine. The EPC-mediated neovascularization and enhancement of myocardial function was observed. In this study we examined the regional biologic mechanisms underlying this therapy.

METHODS: Lewis rats underwent left anterior descending coronary artery (LAD) ligation and developed ischemic cardiomyopathy over 6 weeks. Three weeks after ligation, the animals received either subcutaneous GMCSF and intramyocardial SDF injections or saline injections as control. Six weeks after LAD ligation circulating EPC density was studied by flow cytometry. Quadruple immunofluorescent vessel staining for mature, proliferating vasculature was performed. Confocal angiography was utilized to identify fluorescein lectin-lined vessels to assess perfusion. Ischemia reversal was studied by measuring myocardial adenosine triphosphate (ATP) levels. Myocardial viability was assayed by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling detection of apoptosis and quantitation of myofilament density.

RESULTS: The GMCSF/SDF therapy enhanced circulating leukocyte (13.1 ± 4.5 x 106 vs 3.1 ± 0.5 x 106/cc, p = 0.001, n = 6) and EPC (14.2 ± 6.6 vs 2.2 ± 2.1/cc, p = 0.001, n = 6) concentrations. Tetraimmunofluorescent labeling demonstrated enhanced stable vasculature with this therapy (39.2 ± 8.1 vs 25.4 ± 5.1%, p = 0.006, n = 7). Enhanced perfusion was shown by confocal microangiography of borderzone lectin-labeled vessels (28.2 ± 5.4 vs 11.5 ± 3.0 vessels/high power field [hpf], p = 0.00001, n = 10). Ischemia reversal was demonstrated by enhanced cellular ATP levels in the GMCSF/SDF borderzone myocardium (102.5 ± 31.0 vs 26.9 ± 4.1 nmol/g, p = 0.008, n = 5). Borderzone cardiomyocyte viability was noted by decreased apoptosis (3.2 ± 1.4% vs 5.4 ± 1.0%,p = 0.004, n = 10) and enhanced cardiomyocyte density (40.0 ± 5.6 vs 27.0 ± 6 myofilaments/hpf, p = 0.01, n=10).

CONCLUSIONS: Endogenous revascularization for ischemic cardiomyopathy utilizing GMCSF EPC upregulation and SDF EPC chemokinesis upregulates circulating EPCs, enhances vascular stability, and augments myocardial function by enhancing perfusion, reversing cellular ischemia, and increasing cardiomyocyte viability.




This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
K. Hobo, T. Shimizu, H. Sekine, T. Shin'oka, T. Okano, and H. Kurosawa
Therapeutic Angiogenesis Using Tissue Engineered Human Smooth Muscle Cell Sheets
Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 637 - 643.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. Atluri, C. M. Panlilio, G. P. Liao, E. E. Suarez, R. C. McCormick, W. Hiesinger, J. E. Cohen, M. J. Smith, A. B. Patel, W. Feng, et al.
Transmyocardial revascularization to enhance myocardial vasculogenesis and hemodynamic function.
J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 283 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
Y. Tan, H. Shao, D. Eton, Z. Yang, L. Alonso-Diaz, H. Zhang, A. Schulick, A. S. Livingstone, and H. Yu
Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor
Cardiovasc Res, March 1, 2007; 73(4): 823 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
O. Dormond and J. C. Madsen
Invited commentary.
Ann. Thorac. Surg., May 1, 2006; 81(5): 1736 - 1737.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.